ABIM Neurocritical study materials
ABIM Neurocritical study resources

Refractory intracranial hypertension after severe TBI

ABIM Neurocritical · Put your knowledge to work in context.

All case studies

Refractory intracranial hypertension after severe TBI

A 27-year-old man is admitted after a high-speed motorcycle collision with a scene GCS of 6. He is intubated with a right frontal contusion, a 4-mm acute subdural hematoma, and 5 mm of midline shift on the initial CT. A parenchymal ICP monitor is in place. Over the last 3 hours ICP oscillates between 22 and 30 mmHg with CPP around 58-62 mmHg. He is on propofol 45 mcg/kg/min and fentanyl, temperature 36.6 C, PaCO2 38 mmHg, sodium 139 mmol/L, hemoglobin 9.8 g/dL, and pupils are 3 mm and reactive. During tracheal suctioning the ICP rises to 42 mmHg for 3 minutes. The night float asks whether to hyperventilate him to a PaCO2 of 30 and to call the surgeon for a decompressive craniectomy.

1. Describe your tiered approach over the next 30-60 minutes, including what must be excluded before escalating therapy.

Read the worked answer

Before adding therapy, verify the number and remove the reversible causes - a large share of 'refractory' ICP is artifact or stimulation.

Step 1, confirm and troubleshoot

  • Check the waveform and transducer zero; a parenchymal probe can drift or be malpositioned.
  • Head of bed 30 degrees, midline, loose tube ties, no neck compression.
  • Ensure adequate analgesia/sedation and treat shivering, pain, suctioning, or bladder distension; the 42 mmHg spike during suctioning is a stimulus artifact until proven otherwise.
  • Confirm PaCO2 35-40, adequate oxygenation, normal temperature, sodium, glucose, and hemoglobin; check for seizures if any unexplained fluctuation.
  • Repeat CT for expansion of the contusion, new hematoma, or hydrocephalus.

Step 2, osmotherapy: a bolus of 23.4% saline 30 mL via central line or mannitol 0.5-1 g/kg if hypotensive/volume-contracted and serum osmolality permits.

Step 3, CSF drainage if an EVD is placed, then short-term hyperventilation only as a bridge.

Step 4, refractory: barbiturate coma, temperature control, then surgical consultation.

2. What is the appropriate role of hyperventilation and of osmotherapy in this patient, and what are their limits?

Read the worked answer

Hyperventilation works within minutes by cerebral vasoconstriction, dropping blood volume and ICP - and that same mechanism is why it can cause ischemia. It is a bridge to a definitive intervention (imaging, OR, an osmolar bolus taking effect), not a maintenance strategy:

  • Target PaCO2 30-35 mmHg, never below 30.
  • Never prophylactic; avoid in the first 24 hours when CBF is already lowest.
  • Taper back to normocapnia as soon as the crisis passes; abrupt reversal can rebound ICP.
  • Consider monitoring (jugular bulb oximetry, brain tissue oxygen) to detect ischemia if it must be prolonged.

Osmotherapy is the workhorse. Mannitol 0.5-1 g/kg bolus is fast but causes diuresis, hypovolemia, and hypotension, so it is a poor choice in a hemodynamically tenuous patient; hold if serum osmolality exceeds ~320 mOsm/kg or renal function is failing. Hypertonic saline (23.4%, 30 mL, or 3% continuous) is at least as effective, does not cause hypovolemia, and is preferable here with a CPP of 58. Watch for hypernatremia and hyperchloremic acidosis with repeated dosing. Neither agent should be used as a scheduled order without a defined ICP/clinical trigger and reassessment.

3. Should the surgeon be called for a decompressive craniectomy now? How do the trial data shape your recommendation to the family?

Read the worked answer

Not as a first-line response to a few hours of ICP in the 20s with reactive pupils and a treatable contusion. Escalate medical therapy and re-image first; the surgeon should be called emergently for a mass lesion - an expanding contusion or hematoma with worsening shift - where evacuation is the intervention, and for refractory ICP after maximal medical therapy.

When discussing decompressive craniectomy, be honest that the trials do not show a clean mortality-and-function win:

  • DECRA (bifrontal decompression for diffuse injury, ICP >20 refractory to tier 1-2) reduced ICP and ICU stay but increased unfavorable outcomes at 6 months.
  • RESCUEicp (refractory ICP >25 despite tier 1-2) cut mortality substantially (about 27% vs 49% at 6 months) but shifted survivors into the vegetative and severely disabled categories; the proportion with good recovery was similar or lower.

So the honest framing is a trade of death for survival with severe disability in many patients, which is a values question, not only a technical one. Ask the family what the patient would accept, and revisit the decision if the trajectory is clear.